COLIN CLARK EDGERTON
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology SUMMERVILLE, SC NPI 1245307578
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology SC American Rheumatology Network, LLC All categories
General Payments — all program years on this page
$2,713,487.80
- Category: General Payments
- Program years: PY2018–2024
- Record count: 712
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,510,483.21 across 131 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Acquisitions | $1,500,000.00 | 1 |
| Consulting Fee | $7,425.95 | 2 |
| Food and Beverage | $2,741.99 | 127 |
| Travel and Lodging | $315.27 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| American Rheumatology Network, LLC | $1,500,000.00 | 1 |
| SOBI, INC | $6,177.45 | 10 |
| Amgen Inc. | $2,473.56 | 26 |
| ABBVIE INC. | $520.20 | 28 |
| Janssen Biotech, Inc. | $377.03 | 17 |
| UCB, Inc. | $203.28 | 13 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $178.13 | 9 |
| Organon LLC | $98.60 | 4 |
| Lilly USA, LLC | $83.30 | 4 |
| Acerta Pharma LLC | $78.59 | 4 |
| E.R. Squibb & Sons, L.L.C. | $68.01 | 4 |
| Aurinia Pharma U.S., Inc. | $64.62 | 3 |
| PFIZER INC. | $45.97 | 2 |
| GlaxoSmithKline, LLC. | $34.27 | 2 |
| Kiniksa Pharmaceuticals International, plc | $24.07 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.35 | 1 |
| Fresenius Kabi USA, LLC | $20.75 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.03 | 1 |
By program year
Records — PY2024 (131)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.